-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.O1.6 722. Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Avoiding GVHD and Improving Outcomes

Symposia: Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Clinical trials, Combination therapy, Adult, Elderly, Translational Research, Clinical Research, Biological therapies, Treatment Considerations, Immunology, Biological Processes, Study Population, Human, Transplantation (Allogeneic and Autologous)
Monday, December 9, 2024: 4:30 PM-6:00 PM
Room 6B (San Diego Convention Center)
Moderators:
Yang Xu, MD, The First Affiliated Hospital of Soochow University and Matthew Kudek, MD,
Disclosures:
No relevant conflicts of interest to declare.
4:30 PM

Sameem Abedin, MD1, Fateeha Furqan, MBBS2, Lyndsey Runaas, MD3*, Walter Longo, MD3*, Nirav N. Shah, MD4, Timothy S. Fenske, MD4, Marcelo C. Pasquini, MD, MS5, William R Drobyski, MD6, Xue-Zhong Yu, MD, MSc7 and Mehdi Hamadani, MD8

1Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
2Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
3Medical College of Wisconsin, Division of Hematology/Oncology, Milwaukee, WI
4Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
5Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
6Medical College of Wisconsin, Milwaukee, WI
7Department of Microbiology & Immunology; the Cancer Center, Medical College of Wisconsin, Milaukee, WI
8Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

4:45 PM

Mustafa A. Hyder, MD1, Dimana Dimitrova, MD1*, Ruby Sabina, FNP-BC1*, Ashley DeVries, RN1*, Jeannine S. McCune, BSPharm, PharmD2*, Meredith J. McAdams, MD1*, Francis A. Flomerfelt, PhD3*, Christi McKeown, NP1*, Jennifer L. Sadler, RN3*, Amy Chai, RN1*, Thomas E. Hughes, PharmD4*, Scott Napier, PA-C1*, Anita Stokes, NP1*, Jennifer Sponaugle, PA-C1*, Kamil Rechache, MD1*, Mark Parta, MD5*, Jennifer Cuellar-Rodriguez, MD6*, William D. Figg, PharmD3*, Hyoyoung Choo-Wosoba, PhD3*, Seth M. Steinberg, PhD3*, Jennifer A. Kanakry, MD1* and Christopher G. Kanakry, MD1

1Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Department of Hematologic Malignancies, City of Hope, Duarte, CA
3National Cancer Institute, National Institutes of Health, Bethesda, MD
4Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, MD
5National Institutes of Health, Bethesda, MD
6National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD

5:00 PM

Michela Ansuinelli, MD, PhD1,2*, Haesook T. Kim, PhD3, Carol G. Reynolds, PhD1*, Francesco Malfona, MD1,2*, Shuntaro Ikegawa, MD, PhD1*, Rakuyo Tamada, BA1*, Roman M. Shapiro, MD1, Mahasweta Gooptu, MD4, Rizwan Romee, MD1, Sarah Nikiforow, MD, PhD1, John Koreth, MD, MBBS, PhD, DPhil1, Vincent T. Ho, MD1*, Corey S. Cutler, MD, MPH1, Joseph H. Antin, MD1, Leslie Kean, MD5, Robert J. Soiffer, MD1 and Jerome Ritz, MD1

1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
2Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA
5Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA

5:15 PM

Sameem Abedin, MD1, Qinghua Lian2*, Michael J Martens, PhD3*, Monzr M. Al Malki, MD4, Hany Elmariah, MD, MS5, Mahasweta Gooptu, MD6, Karilyn T. Larkin, MD7, Brian C. Shaffer, MD, MS8, Alison W Loren, MD9, Melhem M. Solh, MD10, Amin M. Alousi, MD11*, Omer Jamy, MD12, Janny M. Yao, PharmD13*, Kristy Applegate14*, Miguel Angel Perales, MD15, Leslie Kean, MD16, Yvonne A. Efebera, MD17, Ran Reshef, MD, MSc18, William Clark, MD, MS19*, Eric Leifer, PhD20*, Mary M. Horowitz, MD21, Richard J. Jones, MD22, Javier Bolanos-Meade, MD23*, Shernan G. Holtan, MD24 and Mehdi Hamadani, MD25

1Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
2Medical College of Wisconsin, Milwaukee, WI
3Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI
4Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
5Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Department of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA
7Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
8Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
9Abramson Cancer Center, University of Pennsylvania Medical Center, Philadelphia, PA
10BMT Group of Georgia, Atlanta, GA
11Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
12O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham, AL
13Pharmacy, City of Hope National Medical Center, Duarte, CA
14Emmes Corporation, Rockville, MD
15Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
16Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
17Blood and Marrow Transplant and Cellular Therapy Program, OhioHealth, Columbus, OH
18Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY
19Virginia Commonwealth University, Richmond, VA
20NHLBI, Bethesda
21Center for International Blood and Marrow Transplant Research (CIBMTR), Minneapolis, MN
22Johns Hopkins University, Baltimore, MD
23Johns Hopkins University Kimmel Cancer Center, Ellicott City, MD
24Department of Medicine, Umn Medical School, Minneapolis, MN
25Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

5:30 PM

Haris Ali, MD1, Dongyun Yang, PhD2*, NI-Chun Tsai, MS2*, Sally Mokhtari, PhD3, Tim W Synold, PharmD4*, Idoroenyi Amanam, MD1, Andrew Artz, MD, MS5, Peter T. Curtin, MD1, Karamjeet S Sandhu, MD1, Anthony S. Stein, MD6, Shukaib Arslan, MD1*, Salman Otoukesh, MD1, Firoozeh Sahebi, MD1*, Joshua Mansour, MD1*, Paul B. Koller, MD6, Amandeep Salhotra, MD1, Ibrahim Aldoss, MD1, Vinod Pullarkat, MD1, Brian J. Ball, MD6, Stephen J. Forman, MD, FACP1, Guido Marcucci7, Monzr M. Al Malki, MD6 and Ryotaro Nakamura, MD1

1Hematology and HCT, City of Hope National Medical Center, Duarte, CA
2Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
3Clinical and Translational Project Development, City of Hope National Medical Center, Duarte, CA
4Cancer Biology-BRI, City of Hope National Medical Center, Duarte, CA
5City of Hope National Medical Center, Duarte, CA
6Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
7Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope Medical Center and Beckman Research Institute, Duarte, CA

5:45 PM

Hengwei Wu, MD1,2,3,4*, Jimin Shi, MD1,2,3,4*, Yi Luo1,2,3,4, Jian Yu, MD1,2,3,4*, Huarui Fu, MD1,2,3,4*, Lizhen Liu, MD1,2,3,4*, Xiaoyu Lai, MD2,3,4,5*, Luxin Yang, MD1,2,3,4*, Yishan Ye, MD1,2,3,4*, Congxiao Zhang, MD1,2,3,4*, Weijie Cao, MD6*, Junjie Cao7*, Xiaojun Xu, MD8*, Xiaoxia Hu9*, Ying Lu7*, He Huang, MD1,2,3,4* and Yanmin Zhao, MD1,2,3,4*

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Liangzhu Laboratory, Zhejiang University, Hangzhou, China
3Institute of Hematology, Zhejiang University, Hangzhou, China
4Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
5Bone Marrow Transplantation Center, Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
6Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
7Department of Hematology, Yinzhou People’s Hospital, Ningbo, China
8Children’s Hospital of Zhejiang University School of Medicine, Hangzhou, China
9Ruijin Hospital, SHANGHAI, China

*signifies non-member of ASH